Category Archives: Cardiac Regeneration

Discover how technology is being used to mitigate heart failure after heart attacks. JUPITER, Fla., March 28, 2022 /PRNewswire-PRWeb/ -- Viewers will learn about recent developments in regenerative medicine in an upcoming episode of the award-winning series, Advancements with Ted Danson, scheduled to broadcast Q3/2022 on Bloomberg. This segment of Advancements will explore Myocardial Infarction (MI) the leading cause of cardiac tissue damage and subsequent development of heart failure. Continue reading →

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this Annual Report on Form 10-K. The following discussion contains forward-looking statements that are based upon current expectations that involve risks, uncertainties and assumptions Continue reading →

EMERYVILLE, CA / ACCESSWIRE / January 10, 2022 / Mercator MedSystems, Inc. (Mercator or the company), announced today that research has begun under a small business technology transfer (STTR) grant for approximately $300,000 funded by the National Institutes of Health (NIH). Preclinical research performed using the grant resources is intended to demonstrate mechanistic effects of local delivery of anti-inflammatory drugs to treat deep vein thrombosis (DVT) Continue reading →

Rapid advancements in stem cell research, development of novel stem cell technology, use of stem cell therapy to treat chronic and rare diseases, and rapid progress of regenerative medicine are some key factors expected to drive market growth NEW YORK, Jan. 10, 2022 /PRNewswire/ -- Reports and Data has published its latest report titled "Stem Cells Market By Product (Adult Stem Cells, Human Embryonic Stem Cells, IPS Cells, and Very Small Embryonic-Like Stem Cells), By Technology (Cell Acquisition, Cell Production, Cryopreservation, and Expansion & Sub-Culture), By Therapies (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy), and By Application (Regenerative Medicine and Drug Discovery & Discovery), and By Region Forecast To 2028." Reports and Data Logo According to the latest report by Reports and Data, the global stem cells market size was USD 10.13 billion in 2020 and is expected to reach USD 19.31 Billion in 2028 and register a revenue CAGR of 8.4% during the forecast period, 2021-2028. Request a Sample Report https://www.reportsanddata.com/sample-enquiry-form/2981 Drivers, Restraints, & Opportunities Stem cells are cells that have the potential to differentiate into different types of cells in the body Continue reading →

An army of digital health technologies like Artificial Intelligence (AI)-powered gadgets like digital stethoscope, electronic tattoos which monitor vitals, miniscule sensors, and smartwatches tracking heartbeats are quickly transforming the traditional preventive tools of Cardiovascular Disease (CVDs). Experts pronounce that digital platforms like augmented reality will break the barriers and change the scenario of cardiac care Continue reading →

This article was originally published here J Clin Invest. 2021 Oct 1;131(19):e138637 Continue reading →

A genetic syndrome that affects bones Osteogenesis Imperfecta (OI) is a hereditary disorder occurring in 1:10,000 births and characterised by osteopenia (bone loss) and skeletal fragility (fractures). Secondary features include short stature, skeletal deformities, blue sclera and dentinogenesis imperfect. (1) There is a large clinical variability in OI, and severity ranges from mild to lethal, based on radiological characteristics Continue reading →

Wireless, battery-free, fully implantable pacemakers made of bioresorbable components could represent the future of temporary pacing technology. Continue reading →

Researchers at Northwestern and George Washington (GW) universities have developed the first-ever transient pacemaker, a wireless, battery-free, fully implantable pacing device that disappears after its no longer needed. Continue reading →

Myocardial revascularization is an alternate procedure for patients suffering from ischemic heart disease and who cannot undergo interventions like heart bypass surgery due to widespread coronary artery disease, procedure failure, small coronary arteries, or cardiac stenosis. Further, reparative stem cells can restore the function of damaged tissue by renewing cell growth in cardiac cells destroyed by heart disease. The key players profiled in the Myocardial Revascularization, Repair, And Regeneration Products And Therapies Market research study includes: Request Sample Copy of Myocardial Revascularization, Repair, And Regeneration Products And Therapies Market research report at Link https://www.theinsightpartners.com/sample/TIPRE00021590/ Since, the key findings in the Myocardial Revascularization, Repair, And Regeneration Products And Therapies Market research reports highlight crucial progressive industry trends, it allows the companies across the value chain to develop effective long-term strategies. Continue reading →